|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 207/00 | (2006.01) |
| C07D 215/48 | (2006.01) | ||
| C07D 217/00 | (2006.01) | ||
| C07D 239/00 | (2006.01) | ||
| C07D 263/24 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 403/12 | (2006.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 31/472 | (2006.01) | ||
| A61K 31/4725 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 17/06 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Patento numeris | 3536685 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19157789.9 |
| Europos patento paraiškos padavimo data | 2015-03-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-02-16 |
| (46) | Apibrėžties vertimo paskelbimo data | 2022-04-25 |
| (30) | Numeris | Data | Šalis |
| 201461975473 P | 2014-04-04 | US |
| (72) |
ANDERSON, David Randolph , US
BUNNAGE, Mark Edward , US
CURRAN, Kevin Joseph , US
DEHNHARDT, Christoph Martin , CA
GAVRIN, Lori Krim , US
GOLDBERG, Joel Adam , US
HAN, Seungil , US
HEPWORTH, David , US
HUANG, Horng-Chih , US
LEE, Arthur , US
LEE, Katherine Lin , US
LOVERING, Frank Eldridge , US
LOWE, Michael Dennis , US
MATHIAS, John Paul , US
PAPAIOANNOU, Nikolaos , US
PATNY, Akshay , US
PIERCE, Betsy Susan , US
SAIAH, Eddine , US
STROHBACH, Joseph Walter , US
TRZUPEK, John David , US
VARGAS, Richard , US
WANG, Xiaolun , US
WRIGHT, Stephen Wayne , US
ZAPF, Christoph Wolfgang , US
|
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Biciklinio sulieto heteroarilo arba arilo junginiai ir jų naudojimas kaip IRAK4 inhibitorių |
| BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-02-09 | 10 | 231.00 EUR |
| 2025-03-26 |